Abstract

Over the last few years, the minimally invasive treatment of haemorrhoidal disease (HD) has been gaining popularity. In this context, sclerotherapy with 3% polidocanol foam is one of the most frequently performed outpatient procedures for II-degree symptomatic HD and in patients with a severe life-threatening bleeding aged more than 75 years or with comorbidities [1-3]. Moreover, even if prospective randomized studies are still needed, the results reported in the literature seem to be favourable in terms of both success and complication rate and cost-effectiveness compared to the treatment with liquid sclerotherapy [4].

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.